NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q4 2023 Earnings Call Transcript

And the areas that they’re looking to evaluate with our technology, and this has been really consistent with other companies that we’re speaking to now. It’s been for epilepsy, which is kind of a slam dunk, given that that’s where our procedures are being done today. Parkinson’s is another one. And then one that was a little bit surprising to me was ALS, so Lou Gehrig’s disease. So that one, we still need to learn a little bit more about how they would want to use our device, and it may be these cortical or the strip electrodes versus the sEEG for that type of procedure.

Ben Haynor: Okay. That’s helpful. That’s all I had, gentlemen. Thanks for taking the questions.

Ron McClurg: Thanks a lot, Ben.

Operator: Thank you. There are no further questions at this time. I’d like to hand the floor back over to management for any closing comments.

Dave Rosa: Yes. Thanks, operator. I just wanted to close with that we really believe the Company has made extraordinary progress towards the goals that we actually set for fiscal 2023. And just to remind everyone of just a handful of these, we received FDA clearance actually on our sEEG electrode during fiscal 2023. We commercially launched that line in May with Zimmer Biomet, our distribution partner. We submitted for FDA clearance on our OneRF Ablation System, obviously, subsequently received FDA clearance for that product as well. In addition, we did raise capital with existing and for me, even more importantly, new institutional investors without including warrants. We launched a drug delivery program and continue to make progress regarding our implantable electrode intended to treat back pain.

I also believe the Company has the potential to add revenue in 2024 beyond sEEG sales, with contributions coming from our ablation system and potentially our drug delivery partnership or partnerships. In closing, I hope you all continue to follow our exciting progress. Thank you. And have a good evening.

Operator: This concludes today’s conference. You may disconnect your lines at this time. Thank you for your participation.